Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
170.80    0.40 (0.23%)
Bid:
171.60
Ask:
171.80
Spread: 0.20 (0.117%)
Market Cap: £1.26b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Grainger plc bond pricing

19 Apr 2018 15:57

RNS Number : 5190L
Grainger PLC
19 April 2018
 

LEI: 2138007CEIRKZMNI2979

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014

 

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES (OR TO U.S. PERSONS), AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

 

 

19 April 2018

 

Grainger plc

 

 

Grainger plc reduces debt cost and extends maturity profile with £350 million senior secured bond

 

 

Grainger plc (the "Group"), the UK's largest listed residential landlord, has priced a £350m sterling-denominated senior secured bond at a coupon of 3.375% for 10 years. The bond was rated BBB- by S&P.

 

The net proceeds from the issue of the Notes will be used to redeem the existing corporate bond (£275m at a coupon of c.5%) that matures in 2020, and for general corporate purposes.

 

In line with the Group's financing strategy, the refinancing achieves both a reduction in cost of debt and an extension of its maturity profile. The pro forma impact of this refinancing on the Group's financial metrics is as follows:

 

§ An annual interest saving of c.£3m, reducing the cost of debt from 3.5% to 3.1%.

 

§ Weighted average debt maturity is extended from 4.7 years to 6.5 years, assuming extension options are exercised. Excluding extension options 5.8 years.

 

§ The estimated prepayment cost net of tax for the existing corporate bond is £21m which would result in EPRA NAV reducing by 5 pence per share. The impact on EPRA NNNAV is expected to be negligible.

 

Vanessa Simms, Chief Financial Officer, said:

 

"We are delighted by the response to this bond issuance. The investor demand is a testament to the successful implementation of our strategy and our growing Private Rented Sector (PRS) portfolio which strengthens our income return.

 

The refinancing is an important milestone in extending our maturity profile and provides long-term interest rate certainty at an attractive coupon, reducing our annual interest costs by £3m."

 

Barclays Bank plc, HSBC Bank plc and The Royal Bank of Scotland plc (trading as NatWest Markets) acted as joint active bookrunners.

 

The manufacturer target market for the purpose of MIFID II product governance is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the Bonds are not available to retail in EEA.

This announcement is not an offer of the Bonds in the United States or any other jurisdiction. Securities may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act").

 

This communication does not constitute an offer of the Bonds to the public in the United Kingdom. This communication is being distributed to and is directed only at (i) persons who are outside the United Kingdom or (ii) persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") and (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "Relevant Persons"). Any investment activity to which this communication relates will only be available to and will only be engaged with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents.

A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

This announcement is an advertisement and not a prospectus for the purposes of Directive 2003/71/EC, as amended.

 

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO OR FOR THE ACCOUNT OF U.S. PERSONS (EACH AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT ("REGULATION S")). THE BONDS HAVE NOT BEEN AND WILL NOT BE REGISTERED IN THE UNITED STATES UNDER THE SECURITIES ACT, AND MAY NOT BE OFFERED, SOLD OR DELIVERED IN THE UNITED STATES (AS SUCH TERM IS DEFINED IN REGULATION S) OR TO OR FOR THE ACCOUNT OF U.S. PERSONS (AS SUCH TERM IS DEFINED IN REGULATION S) UNLESS THE BONDS ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE.

FCA/ICMA stabilisation.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGMDDLRGRZM
Date   Source Headline
5th Dec 201711:02 amRNSDirector/PDMR Shareholding
4th Dec 20172:06 pmRNSDirector Declaration
1st Dec 201711:21 amRNSDirector Declaration
30th Nov 20177:00 amRNSFull Year Results
24th Nov 20177:00 amRNSAcquisition
23rd Nov 201710:08 amRNSDirector Declaration
23rd Nov 20177:00 amRNSAcquisition
13th Nov 201712:18 pmRNSTotal Voting Rights
7th Nov 20173:49 pmRNSDirector/PDMR Shareholding
2nd Nov 201712:18 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSNotice of Preliminary Results & 2018 Calendar
16th Oct 201712:46 pmRNSDirectorate Change
10th Oct 20172:22 pmRNSTotal Voting Rights
6th Oct 201710:52 amRNSDirector/PDMR Shareholding
3rd Oct 20173:11 pmRNSBlock listing Interim Review
3rd Oct 20173:10 pmRNSBlock listing Interim Review
27th Sep 20177:00 amRNSPre-Close Statement & Capital Markets Day
20th Sep 201710:31 amRNSDirector/PDMR Shareholding
13th Sep 20172:09 pmRNSDirector/PDMR Shareholding
12th Sep 201711:32 amRNSTotal Voting Rights
30th Aug 20179:30 amRNSDirectorate Change
29th Aug 20177:00 amRNS£80m build-to-rent scheme in Salford
8th Aug 201711:24 amRNSTotal Voting Rights
7th Aug 20173:48 pmRNSDirector/PDMR Shareholding
2nd Aug 20172:33 pmRNSHolding(s) in Company
1st Aug 20177:00 amRNS£30.5M PRS Acquisition
24th Jul 20177:00 amRNSAcquisition of PRS build-to-rent development
18th Jul 20173:52 pmRNSHolding(s) in Company
5th Jul 20179:33 amRNSDirector/PDMR Shareholding
5th Jul 20179:31 amRNSTotal Voting Rights
4th Jul 20174:08 pmRNSHolding(s) in Company
30th Jun 20171:55 pmRNSDirector Declaration
8th Jun 201711:28 amRNSDirector/PDMR Shareholding
6th Jun 20171:55 pmRNSTotal Voting Rights
6th Jun 201711:44 amRNSDirector/PDMR Shareholding
2nd Jun 20174:11 pmRNSHolding(s) in Company
24th May 201711:40 amRNSHolding(s) in Company
19th May 20177:00 amRNSHalf Year Results
8th May 20172:59 pmRNSDirector/PDMR Shareholding
5th May 20172:18 pmRNSHolding(s) in Company
4th May 20173:02 pmRNSTotal Voting Rights
20th Apr 201711:22 amRNSHolding(s) in Company
6th Apr 20174:22 pmRNSHolding(s) in Company
6th Apr 201711:29 amRNSTotal Voting Rights
6th Apr 201710:39 amRNSDirector/PDMR Shareholding
3rd Apr 20174:23 pmRNSBlock listing Interim Review
3rd Apr 20174:20 pmRNSBlock listing Interim Review
9th Mar 20174:00 pmRNSTotal Voting Rights
8th Mar 201711:07 amRNSDirector/PDMR Shareholding
7th Mar 20174:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.